Close

Leerink Boosts PT on Mallinckrodt (MNK) to $92; Lifts INOMax Expectations

Go back to Leerink Boosts PT on Mallinckrodt (MNK) to $92; Lifts INOMax Expectations

Mallinckrodt (MNK) wins IPR decisions on INOMax blood-vessel drug - Bloomberg

September 16, 2016 9:56 AM EDT

Mallinckrodt (NYSE: MNK) wins IPR decisions on INOMax blood-vessel drug, according to Bloomberg.

... More